Last reviewed · How we verify

Estradiol Transdermal Product

Eastern Virginia Medical School · Phase 2 active Small molecule

Estrogen receptor agonist

Estrogen receptor agonist Used for Treatment of estrogen deficiency symptoms, Prevention of osteoporosis.

At a glance

Generic nameEstradiol Transdermal Product
Also known asMicronized progesterone
SponsorEastern Virginia Medical School
Drug classEstrogen agonist
TargetEstrogen receptor
ModalitySmall molecule
Therapeutic areaOncology
PhasePhase 2

Mechanism of action

Estradiol acts as an estrogen receptor agonist, binding to estrogen receptors and activating them, which leads to various physiological effects.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: